BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,976 | -25.2% | 78,860 | -9.7% | 0.04% | -20.4% |
| Q2 2023 | $3,980 | -99.8% | 87,360 | +76.6% | 0.05% | +81.5% |
| Q1 2023 | $2,006,098 | -37.2% | 49,460 | -21.1% | 0.03% | -40.0% |
| Q4 2022 | $3,193,780 | -57.0% | 62,660 | -45.8% | 0.04% | -51.6% |
| Q3 2022 | $7,424,000 | -42.2% | 115,579 | -37.7% | 0.09% | +31.0% |
| Q2 2022 | $12,842,000 | +137.0% | 185,458 | +165.4% | 0.07% | +34.0% |
| Q1 2022 | $5,418,000 | -43.4% | 69,879 | -37.3% | 0.05% | -36.9% |
| Q4 2021 | $9,564,000 | -6.0% | 111,419 | -12.0% | 0.08% | -10.6% |
| Q3 2021 | $10,179,000 | -8.7% | 126,563 | -8.7% | 0.09% | -7.8% |
| Q2 2021 | $11,154,000 | -9.8% | 138,563 | -5.5% | 0.10% | -9.7% |
| Q1 2021 | $12,370,000 | +3.5% | 146,663 | -1.5% | 0.11% | 0.0% |
| Q4 2020 | $11,953,000 | +62.3% | 148,963 | +62.7% | 0.11% | +41.2% |
| Q3 2020 | $7,363,000 | -0.3% | 91,563 | +6.8% | 0.08% | -14.0% |
| Q2 2020 | $7,384,000 | +24.1% | 85,763 | +17.1% | 0.09% | -3.1% |
| Q1 2020 | $5,948,000 | -15.5% | 73,263 | -13.0% | 0.10% | +11.6% |
| Q4 2019 | $7,038,000 | -46.9% | 84,163 | -44.5% | 0.09% | -50.3% |
| Q3 2019 | $13,266,000 | +10.1% | 151,661 | +3.1% | 0.17% | +12.3% |
| Q2 2019 | $12,051,000 | -2.5% | 147,144 | -3.2% | 0.15% | -0.6% |
| Q1 2019 | $12,363,000 | +65.7% | 152,044 | +34.2% | 0.16% | +20.2% |
| Q4 2018 | $7,460,000 | -30.7% | 113,338 | -18.8% | 0.13% | -18.9% |
| Q3 2018 | $10,765,000 | +0.2% | 139,638 | -4.1% | 0.16% | -1.9% |
| Q2 2018 | $10,748,000 | +21.4% | 145,556 | +6.9% | 0.16% | +20.0% |
| Q1 2018 | $8,856,000 | +1.4% | 136,158 | +0.7% | 0.14% | +2.3% |
| Q4 2017 | $8,737,000 | +18.2% | 135,168 | +14.7% | 0.13% | -6.4% |
| Q3 2017 | $7,394,000 | +6.7% | 117,840 | +3.0% | 0.14% | +0.7% |
| Q2 2017 | $6,929,000 | +35.0% | 114,453 | +15.6% | 0.14% | +13.8% |
| Q1 2017 | $5,134,000 | +9.4% | 98,999 | -6.5% | 0.12% | +11.8% |
| Q4 2016 | $4,694,000 | -12.9% | 105,862 | -6.5% | 0.11% | -6.8% |
| Q3 2016 | $5,391,000 | +8.5% | 113,266 | +3.1% | 0.12% | +2.6% |
| Q2 2016 | $4,970,000 | -4.0% | 109,913 | -12.8% | 0.12% | -4.2% |
| Q1 2016 | $5,176,000 | +24.0% | 126,007 | +15.2% | 0.12% | +9.1% |
| Q4 2015 | $4,174,000 | +19.0% | 109,394 | +2.4% | 0.11% | +12.2% |
| Q3 2015 | $3,509,000 | -56.8% | 106,818 | -8.1% | 0.10% | -50.0% |
| Q2 2015 | $8,128,000 | -2.5% | 116,233 | -4.5% | 0.20% | +2.1% |
| Q1 2015 | $8,340,000 | -12.9% | 121,754 | -6.8% | 0.19% | -7.7% |
| Q4 2014 | $9,579,000 | -2.4% | 130,695 | -4.5% | 0.21% | -1.0% |
| Q3 2014 | $9,818,000 | -8.6% | 136,797 | -7.9% | 0.21% | -1.4% |
| Q2 2014 | $10,743,000 | -6.5% | 148,596 | -4.9% | 0.21% | -6.6% |
| Q1 2014 | $11,494,000 | +9.7% | 156,216 | +3.7% | 0.23% | +4.1% |
| Q4 2013 | $10,477,000 | -0.5% | 150,639 | -6.0% | 0.22% | -3.5% |
| Q3 2013 | $10,530,000 | -12.0% | 160,301 | -7.2% | 0.23% | -8.8% |
| Q2 2013 | $11,964,000 | – | 172,717 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |